ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2019 American Transplant Congress

    Mesangiopathic Glomerulonephritis in Kidney Transplants

    G. Towns, G. Agarwal, S. Ong, R. Mundra, C. Kew

    UAB, Birmingham, AL

    *Purpose: Describe higher than anticipated prevalence of Mesangiopathic Glomerulonephritis on surveillance biopsies.*Methods: Review of all surveillance biopsies from September 2014 through September 2018 for presence…
  • 2019 American Transplant Congress

    Development of a Recurrence Risk Score in IgA Nephropathy after Kidney Transplantation: Role of Recipient Age and HLA-B Mismatch

    L. M. Rodas Marin1, E. Ruiz2, A. García3, M. Blasco1, P. Ventura1, E. de Soussa1, O. Viñas4, F. Diekmann1, L. Quintana1

    1Nephrology and Renal Trasplantation, Hospital Clinic, Barcelona, Spain, 2Immunology, Hospital Clinic, Barcelona, Spain, 3Pathology, Hospital Clinic, Barcelona, Spain, 4Inmunology, Hospital Clinic, Barcelona, Spain

    *Purpose: Recurrence of IgA nephropathy is an important and growing cause of kidney allograft dysfunction. The purpose of this observational retrospective study was to characterize…
  • 2019 American Transplant Congress

    Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients

    D. Salerno1, N. Lange1, E. Simoneau2, C. Sammons3, D. Bley1, R. S. Brown Jr4, J. Emond2, K. Halazun5

    1Pharmacy, NewYork-Presbyterian Hospital, New York, NY, 2Surgery, Columbia University Irving Medical Center, New York, NY, 3Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, 4Medicine, Weill Cornell Medicine, New York, NY, 5Surgery, Weill Cornell Medicine, New York, NY

    *Purpose: The optimal immunosuppression for liver transplant recipients (LTR) with hepatocellular carcinoma (HCC) is unknown. Basiliximab, an interleukin-2 receptor antagonist (IL-2RA), confers immunosuppression for LTR…
  • 2019 American Transplant Congress

    The Evolution of Body Mass Index after Kidney Transplantation in Recipients with a Previous Laparoscopic Sleeve Gastrectomy

    G. Chan, F. Briere

    Universite de Montreal, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

    *Purpose: Bariatric surgery is one of the most common operations. Laparoscopic sleeve gastrectomy (LSG) has been reported to prepare candidates for listing. However, weight gain…
  • 2019 American Transplant Congress

    Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients

    B. Clark1, D. D. Ramirez1, A. Carlson1, B. Sirandas1, C. Truax1, L. Smith1, I. Hall2

    1Solid Organ Transplant, University of Utah Health, Salt Lake City, UT, 2Nephrology and Hypertension, University of Utah Health, Salt Lake City, UT

    *Purpose: Over half of solid organ transplant recipients (SOTR) develop nonmelanoma skin cancers (NMSC) and up to 80% experience recurrence. Many immunosuppressive drugs are known…
  • 2019 American Transplant Congress

    Risk Factors for Recurrence and Predictors of Response in Kidney Transplant Recipients with Primary FSGS

    A. Uffing1, T. TANGO-consortium2, P. Cravedi3, L. V. Riella1

    1Renal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 2NA, Boston, MA, 3Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

    *Purpose: Primary focal segmental glomerulosclerosis (FSGS) is a glomerular disease that frequently recurs after kidney transplantation. Several circulating factors have been proposed to cause recurrence…
  • 2019 American Transplant Congress

    Predicting HCC Recurrence Following Liver Transplant – A Machine Learning Approach

    L. F. Lau1, W. Nelson2, A. Gorgen1, L. Erdman2, P. Abreu1, A. Goldenberg2, G. Sapisochin1

    1Department of Surgery, University of Toronto, Toronto, ON, Canada, 2The Center for Computational Medicine, The Hospital for Sick Children, Toronto, ON, Canada

    *Purpose: The liver transplant listing criteria for hepatocellular carcinoma (HCC) is controversial. Policies aim to prevent tumor recurrence but it has been difficult to encompass…
  • 2019 American Transplant Congress

    Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy

    C. Kuscu1, V. Sai Bontha1, C. Kuscu1, D. Maluf1, A. Bajwa1, J. Eason1, V. Mas1, E. Akalin2

    1UTHSC, Memphis, TN, 2Albert Einstein College of Medicine, NYC, NY

    *Purpose: Post-transplant glomerular disease includes membranous glomerulopathy (MG), secondary or primary focal segmental glomerulosclerosis (FSGS). Furthermore, at post transplant, TG is an important cause of…
  • 2018 American Transplant Congress

    Preemptive Rituximab in Focal and Segmental Glomerulosclerosis Patients at Risk for Recurrence after Transplantation

    P. Auñon,1 N. Polanco,1 M. Perez,2 E. Rodrigo,3 A. Sancho,4 J. Pascual,2 A. Andres,1 M. Praga.1

    1Nephrology Department, Hospital Doce de Octubre, Madrid, Spain; 2Nephrology Department, Hospital del Mar, Barcelona, Spain; 3Nephrology Department, Hospital Marques de Valdecilla, Santander, Spain; 4Nephrology Department, Hospital Doctor Peset, Valencia, Spain.

    INTRODUCTIONRecurrence of focal and segmental glomerulosclerosis (FSGS) after renal transplantation is a characteristic complication of the disease that occurs in one third of the cases.…
  • 2018 American Transplant Congress

    Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants

    J. Leventhal,1 L. Gallon,1 J. Mathew,1 J. Miller,1 D. Stare,1 S. Ildstad.2

    1Northwestern U, Chicago; 2U Louisville, Louisville.

    Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences